Ian F. Smith is Executive Chairman of Solid’s Board and has served as a member of Solid’s Board of Directors since April 2020 and served as a consultant to Solid from February 2020 to December 2021. Mr. Smith currently serves as director and Executive Chair of the board of ViaCyte, Inc., a private biotechnology company. He is also a member of the Board of Foghorn Therapeutics, a public biotechnology company and is a Senior Advisor to Bain Capital Life Sciences. Between 2001 and 2019, Mr. Smith served as Executive Vice President and Chief Operating Officer, and Chief Financial Officer at Vertex Pharmaceuticals, a public biotechnology company.
He received a B.A. with honors in accounting and finance from Manchester Metropolitan University (UK).